Phase I study of DMP 840 in pediatric patients with refractory solid tumors
- 1 March 1998
- journal article
- clinical trial
- Published by Springer Nature in Investigational New Drugs
- Vol. 16 (1) , 45-49
- https://doi.org/10.1023/a:1006014510078
Abstract
The bis-naphthalimide DMP 840 has demonstrated high level antitumor activity in a number of preclinical models and has been evaluated in several Phase I studies in adults. We enrolled 10 patients...Keywords
This publication has 3 references indexed in Scilit:
- Successful treatment of metastatic choriocarcinoma after DMP 840Urologic Oncology: Seminars and Original Investigations, 1995
- Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancersCancer Chemotherapy and Pharmacology, 1994